Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
Clinical trial NCT01715805 · COMPLETED
Trial details
- NCT number
- NCT01715805
- Sponsor
- Forest Laboratories
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-15
- Primary completion
- 2016-06-24
- Enrollment
- 1022
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.